Cargando…

Potential Effects of Cannabidiol as a Wake-Promoting Agent

Over the last decades, the scientific interest in chemistry and pharmacology of cannabinoids has increased. Most attention has focused on ∆(9)-tetrahydrocannabinol (∆(9)-THC) as it is the psychoactive constituent of Cannabis sativa (C. sativa). However, in previous years, the focus of interest in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murillo-Rodríguez, Eric, Sarro-Ramírez, Andrea, Sánchez, Daniel, Mijangos-Moreno, Stephanie, Tejeda-Padrón, Alma, Poot-Aké, Alwin, Guzmán, Khalil, Pacheco-Pantoja, Elda, Arias-Carrión, Oscar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023456/ https://www.ncbi.nlm.nih.gov/pubmed/24851090 http://dx.doi.org/10.2174/1570159X11666131204235805

Ejemplares similares

Administration of URB597, Oleoylethanolamide or Palmitoylethanolamide Increases Waking and Dopamine in Rats
por: Murillo-Rodríguez, Eric, et al.
Publicado: (2011)

Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023)

Role of N-Arachidonoyl-Serotonin (AA-5-HT) in Sleep-Wake Cycle Architecture, Sleep Homeostasis, and Neurotransmitters Regulation
por: Murillo-Rodríguez, Eric, et al.
Publicado: (2017)

Effects of Hypocretin/Orexin Cell Transplantation on Narcoleptic-Like Sleep Behavior in Rats
por: Arias-Carrión, Oscar, et al.
Publicado: (2014)

The Effects of Food on Cannabidiol Bioaccessibility
por: Mozaffari, Khadijeh, et al.
Publicado: (2021)

Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent
por: Aebersold, Alyssa, et al.
Publicado: (2021)

No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
por: Linares, Ila M. P., et al.
Publicado: (2018)

Basal forebrain control of wakefulness and cortical rhythms
por: Anaclet, Christelle, et al.
Publicado: (2015)

Cannabidiol for neurodegenerative disorders: A comprehensive review
por: Bhunia, Sukanya, et al.
Publicado: (2022)

Molecular mechanism of the wake-promoting agent TAK-925
por: Yin, Jie, et al.
Publicado: (2022)

Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents
por: Dias Viegas, Flávia P., et al.
Publicado: (2022)

Assessing the treatment of cannabidiolic acid methyl ester: a stable synthetic analogue of cannabidiolic acid on c-Fos and NeuN expression in the hypothalamus of rats
por: Murillo-Rodríguez, Eric, et al.
Publicado: (2021)

Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
por: Abbotts, Kieran Shay Struebin, et al.
Publicado: (2022)

The yearly rate of Relative Thalamic Atrophy (yrRTA): a simple 2D/3D method for estimating deep gray matter atrophy in Multiple Sclerosis
por: Menéndez-González, Manuel, et al.
Publicado: (2014)

Wakefulness
Publicado: (1869)

Wakefulness
Publicado: (1864)

Wakefulness
Publicado: (1876)

Wakefulness
Publicado: (1880)

Wakefulness
Publicado: (1881)

Wakefulness
Publicado: (1878)

Wakefulness
Publicado: (1884)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

The antimicrobial potential of cannabidiol
por: Blaskovich, Mark A. T., et al.
Publicado: (2021)

Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021)

The Polypharmacological Effects of Cannabidiol
por: Castillo-Arellano, Jorge, et al.
Publicado: (2023)

Evaluation of Anthropometric Indices and Lipid Parameters to Predict Metabolic Syndrome Among Adults in Mexico
por: Datta Banik, Sudip, et al.
Publicado: (2021)

Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users
por: Fortin, Davide, et al.
Publicado: (2021)

Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves
por: Meyer, Kelsey, et al.
Publicado: (2022)

Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges
por: Green, Ryan, et al.
Publicado: (2022)

Therapeutic Interventions for Vascular Parkinsonism: A Systematic Review and Meta-analysis
por: Miguel-Puga, Adán, et al.
Publicado: (2017)

Dopaminergic reward system: a short integrative review
por: Arias-Carrión, Oscar, et al.
Publicado: (2010)

An agent-based model for supply chain recovery in the wake of the COVID-19 pandemic
por: Rahman, Towfique, et al.
Publicado: (2021)

Basic mechanisms of rTMS: Implications in Parkinson's disease
por: Arias-Carrión, Oscar
Publicado: (2008)

Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils
por: Kitamura, Masashi, et al.
Publicado: (2020)

Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from Cannabis sativa L.
por: Martinenghi, Laura Daniela, et al.
Publicado: (2020)

Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses
por: Umpierrez, Laísa S., et al.
Publicado: (2022)

Cannabidiol: potential in treatment of neurological diseases, flax as a possible natural source of cannabidiol
por: Storozhuk, Maksim V.
Publicado: (2023)

Differences in MTHFR and LRRK2 variant’s association with sporadic Parkinson’s disease in Mexican Mestizos correlated to Native American ancestry
por: Romero-Gutiérrez, Elizabeth, et al.
Publicado: (2021)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

Cannabidiol in epilepsy: The indications and beyond
por: Ryan, Melody
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k9skfs1av3poiiih06esij5hl5